A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Lyme Disease Ab with Reflex to Blot (IgG, IgM) (LYMABY)
Test CodeLAB2330
Quest Code
6646
CPT Codes
86618
Includes
If Lyme Disease Antibody Screen is ≥0.90, then Lyme Disease Antibodies (IgG, IgM), Immunoblot will be performed at an additional charge (CPT code(s): 86617 x2).
Preferred Specimen
1 mL serum in gold top tube
Minimum Volume
0.7 mL
Other Acceptable Specimens
Plain red top tube
Transport Container
Transport tube
Transport Temperature
Refrigerate
Specimen Stability
Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Grossly lipemic • Grossly icteric
Methodology
Immunoassay (IA)
Setup Schedule
Set up 7: 00am; Exp rel 5: 00pm Monday, wednesday, friday (october through march) monday, tuesday, wednesday, thursday, friday (apr. Through sept)
Report Available
3 days
Reference Range
Index | Interpretation |
<0.90 | Negative |
0.90-1.09 | Equivocal |
>1.09 | Positive |
The screening test and/or blot for B. burgdorferi antibodies may be falsely negative in early stages of Lyme disease, including the period when erythema migrans is apparent.
Clinical Significance
Lyme disease is caused by a bacterium borrelia burgdorferi and is transmitted by ticks. A screening test with high sensitivity is used as the first step in the CDC recommended algorithm. Immunoblot testing qualitatively examines, with high specificity, antibodies in a patient's specimen. Immunoblot testing is appropriate for confirming a detected screening result.
Performing Laboratory
Quest Diagnostics - South Region |